Suppr超能文献

迈向精准戒烟治疗 I:析因实验的调节变量结果

Toward precision smoking cessation treatment I: Moderator results from a factorial experiment.

作者信息

Piper Megan E, Schlam Tanya R, Cook Jessica W, Smith Stevens S, Bolt Daniel M, Loh Wei-Yin, Mermelstein Robin, Collins Linda M, Fiore Michael C, Baker Timothy B

机构信息

Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, United States; University of Wisconsin School of Medicine and Public Health, Department of Medicine, Division of General Internal Medicine, United States.

Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health, United States; University of Wisconsin School of Medicine and Public Health, Department of Medicine, Division of General Internal Medicine, United States.

出版信息

Drug Alcohol Depend. 2017 Feb 1;171:59-65. doi: 10.1016/j.drugalcdep.2016.11.025. Epub 2016 Nov 25.

Abstract

BACKGROUND

The development of tobacco use treatments that are effective for all smokers is critical to improving clinical and public health. The Multiphase Optimization Strategy (MOST) uses highly efficient factorial experiments to evaluate multiple intervention components for possible inclusion in an optimized tobacco use treatment. Factorial experiments permit analyses of the influence of patient characteristics on main and interaction effects of multiple, relatively discrete, intervention components. This study examined whether person-factor and smoking characteristics moderated the main or interactive effects of intervention components on 26-week self-reported abstinence rates.

METHODS

This fractional factorial experiment evaluated six smoking cessation intervention components among primary care patients (N=637): Prequit Nicotine Patch vs. None, Prequit Nicotine Gum vs. None, Preparation Counseling vs. None, Intensive Cessation In-Person Counseling vs. Minimal, Intensive Cessation Telephone Counseling vs. Minimal, and 16 vs. 8 Weeks of Combination Nicotine Replacement Therapy (NRT; nicotine patch+nicotine gum).

RESULTS

Both psychiatric history and smoking heaviness moderated intervention component effects. In comparison with participants with no self-reported history of a psychiatric disorder, those with a positive history showed better response to 16- vs. 8-weeks of combination NRT, but a poorer response to counseling interventions. Also, in contrast to light smokers, heavier smokers showed a poorer response to counseling interventions.

CONCLUSIONS

Heavy smokers and those with psychiatric histories demonstrated a differential response to intervention components. This research illustrates the use of factorial designs to examine the interactions between person characteristics and relatively discrete intervention components. Future research is needed to replicate these findings.

摘要

背景

开发对所有吸烟者都有效的烟草使用治疗方法对于改善临床和公共卫生至关重要。多阶段优化策略(MOST)使用高效的析因实验来评估多个干预组件,以便将其纳入优化的烟草使用治疗方法中。析因实验允许分析患者特征对多个相对离散的干预组件的主效应和交互效应的影响。本研究调查了个人因素和吸烟特征是否调节了干预组件对26周自我报告戒烟率的主效应或交互效应。

方法

这项部分析因实验评估了初级保健患者(N = 637)中的六个戒烟干预组件:戒烟前尼古丁贴片与无贴片、戒烟前尼古丁口香糖与无口香糖、戒烟准备咨询与无咨询、强化戒烟面对面咨询与最少咨询、强化戒烟电话咨询与最少咨询,以及16周与8周的联合尼古丁替代疗法(NRT;尼古丁贴片+尼古丁口香糖)。

结果

精神病史和吸烟量均调节了干预组件的效果。与无自我报告精神疾病史的参与者相比,有阳性病史的参与者对16周与8周的联合NRT反应更好,但对咨询干预的反应较差。此外,与轻度吸烟者相比,重度吸烟者对咨询干预的反应较差。

结论

重度吸烟者和有精神病史的人对干预组件表现出不同的反应。本研究说明了使用析因设计来检查个人特征与相对离散的干预组件之间的相互作用。需要进一步的研究来重复这些发现。

相似文献

1
Toward precision smoking cessation treatment I: Moderator results from a factorial experiment.
Drug Alcohol Depend. 2017 Feb 1;171:59-65. doi: 10.1016/j.drugalcdep.2016.11.025. Epub 2016 Nov 25.
2
Toward precision smoking cessation treatment II: Proximal effects of smoking cessation intervention components on putative mechanisms of action.
Drug Alcohol Depend. 2017 Feb 1;171:50-58. doi: 10.1016/j.drugalcdep.2016.11.027. Epub 2016 Nov 24.
3
Identifying effective intervention components for smoking cessation: a factorial screening experiment.
Addiction. 2016 Jan;111(1):129-41. doi: 10.1111/add.13162. Epub 2015 Nov 19.
4
Effects of motivation phase intervention components on quit attempts in smokers unwilling to quit: A factorial experiment.
Drug Alcohol Depend. 2019 Apr 1;197:149-157. doi: 10.1016/j.drugalcdep.2019.01.011. Epub 2019 Feb 16.
5
Can we increase smokers' adherence to nicotine replacement therapy and does this help them quit?
Psychopharmacology (Berl). 2018 Jul;235(7):2065-2075. doi: 10.1007/s00213-018-4903-y. Epub 2018 Apr 25.
7
Effect of nicotine replacement therapy on quitting by young adults in a trial comparing cessation services.
J Public Health Manag Pract. 2014 Mar-Apr;20(2):E7-E15. doi: 10.1097/PHH.0b013e3182a0b8c7.
8
Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant.
Nicotine Tob Res. 2013 Mar;15(3):718-28. doi: 10.1093/ntr/nts186. Epub 2012 Sep 19.
9
A Randomized Controlled Trial of an Optimized Smoking Treatment Delivered in Primary Care.
Ann Behav Med. 2018 Sep 13;52(10):854-864. doi: 10.1093/abm/kax059.
10

引用本文的文献

2
Differences in the effectiveness of individual-level smoking cessation interventions by socioeconomic status.
Cochrane Database Syst Rev. 2025 Jan 27;1(1):CD015120. doi: 10.1002/14651858.CD015120.pub2.
4
Intervention Optimization: A Paradigm Shift and Its Potential Implications for Clinical Psychology.
Annu Rev Clin Psychol. 2024 Jul;20(1):21-47. doi: 10.1146/annurev-clinpsy-080822-051119. Epub 2024 Jul 2.
6
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.
Cochrane Database Syst Rev. 2023 Jun 19;6(6):CD013308. doi: 10.1002/14651858.CD013308.pub2.
7
Strategies to improve smoking cessation rates in primary care.
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD011556. doi: 10.1002/14651858.CD011556.pub2.
9
Self-efficacy as a pathway to long-term smoking cessation among low-income parents in the multilevel Kids Safe and Smokefree intervention.
Drug Alcohol Depend. 2019 Nov 1;204:107496. doi: 10.1016/j.drugalcdep.2019.05.027. Epub 2019 Aug 24.
10
Subtypes in patients with opioid misuse: A prognostic enrichment strategy using electronic health record data in hospitalized patients.
PLoS One. 2019 Jul 16;14(7):e0219717. doi: 10.1371/journal.pone.0219717. eCollection 2019.

本文引用的文献

1
Identifying effective intervention components for smoking cessation: a factorial screening experiment.
Addiction. 2016 Jan;111(1):129-41. doi: 10.1111/add.13162. Epub 2015 Nov 19.
2
Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis.
Nicotine Tob Res. 2016 May;18(5):1002-11. doi: 10.1093/ntr/ntv207. Epub 2015 Oct 6.
5
Long-term nicotine replacement therapy: a randomized clinical trial.
JAMA Intern Med. 2015 Apr;175(4):504-11. doi: 10.1001/jamainternmed.2014.8313.
6
Current cigarette smoking among adults--United States, 2005-2013.
MMWR Morb Mortal Wkly Rep. 2014 Nov 28;63(47):1108-12.
7
Anhedonia as a component of the tobacco withdrawal syndrome.
J Abnorm Psychol. 2015 Feb;124(1):215-25. doi: 10.1037/abn0000016. Epub 2014 Nov 10.
9
Parsing Anhedonia: Translational Models of Reward-Processing Deficits in Psychopathology.
Curr Dir Psychol Sci. 2013 Jun 1;22(3):244-249. doi: 10.1177/0963721412474460.
10
Smoking cessation interventions for smokers with current or past depression.
Cochrane Database Syst Rev. 2013 Aug 21(8):CD006102. doi: 10.1002/14651858.CD006102.pub2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验